Oncologix increases sales ‘organically’
LAFAYETTE, La. – Oncologix on July 21 reported net revenues of $1.2 million for the three months ended May 31, 2015, compared to $988,000 for the same period last year, a 25% increase.
The medical holding company reported net revenues of $3.6million for the nine months ended May 31, 2015, compared to $2.7 million for the same period last year, a 34% increase.
“We are very pleased with the results of our third quarter fiscal 2015. We increased our division sales revenues by organic growth and we will continue to focus on debt reduction over the next three months," said CEO Wayne Erwin in a release.
Over the past nine months Oncologix has obtained 10 new respiratory physician referral sources for increased revenues of $180,000; revamped staffing and consolidated positional responsibilities in both Amian Health and Esteemcare, which it acquired in September 2014; and opened an additional office in South Carolina to expand respiratory therapy services into three new MSA markets.